19th Annual Biosimilars Congregation 2024
“Uniting market leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars”
11th December 2024 Hotel Kohinoor Continental Mumbai India
Virtue Insight is proud to announce that 19th Annual Biosimilars Congregation 2024 happening on 11th December 2024 Hotel Kohinoor Continental Mumbai India.
Please contact Email – [email protected] or Call - +91 44 24762472/ M: +91 9361957193
SPONSORSHIP:
Conference Sponsor & Exhibition Stall – Should you wish to Sponsor or purchase a Exhibition Stall (Booth) or a paid Speaker Slot you can simply email your interest and queries [email protected]
DELEGATE REGISTRATION:
Super Early Bird Discount Price (Valid till 18th Oct 2024) - INR 11000 + GST per delegate
Early Bird Discount Price (Valid till 19th Oct 2024 – 22nd Nov 2024) - INR 14000 + GST per delegate
Standard Price - INR 16000 + GST per delegate
KEY SPEAKERS:
SANJEEV GUPTA Sr. Vice President & Head Biosimilar Ipca Laboratories
SD SINHA Senior VP Development Hetero Labs
ABIR BANERJEE VP & Head R&D Biotech Bharat Serums and Vaccines
SANTOSH TAUR Director Medical Affairs Vaccines Rare Diseases & Digital Pfizer
MANNAN KHAMBATI Assistant VP Biotech Manufacturing Bharat Serums and Vaccines
SOURABH FULMALI Global Medical Director GSK
SANCHIT NANDA Senior Director Global Patient Solutions Gilead Sciences
AMARNATH SUGUMARAN Associate Director & Cluster Head Medical Affairs Cipla
UDAY HARLE Asst. VP/ Global Head Clinical Development Kashiv BioSciences
ABHISHEK SINHA Global Director - Regulatory Affairs Advanz Pharma
AKSHAYA ODAK Head - Regulatory Affairs (Biotech) Lupin
MILIND ANTANI Leader Pharma and Healthcare Nishith Desai Associates
PRITHWIJIT KUNDU CMO - NCE NDD Wockhardt
PANKAJ THAKUR GM Clinical Project Management - Drug Discovery Biologics Hetero Labs
DATTATRAY PAWAR Head Medical Affairs - Deputy GM Alkem Laboratories
SEEMA BHANDARKAR Global Program Manager Biosimilar Operations Biocon
UMA SINHA DATTA Director PDS India Cytiva
SANJAY B. NIRANJAN Assistant Director Bioassay Development (Biosimilars) Lupin
ANURAG TIWARI AVP R&D Zumutor Biologics
KAVITA LAMROR Partner RWE & Digital Transformation Maxis Clinical Sciences
ROSHAN PAWAR Head Medical Affairs Alkem Laboratories
SAMIR KULKARNI Head - DBT ICT Center Institute Of Chemical Technology
SWEETY MATHEW Regulatory Professional- Global Regulatory Affairs: CMC Rare Diseases Novo Nordisk
RANJIT BARSHIKAR CEO QBD International United Nations Adviser
SHALU KASLIWAL Group Lead - Medical Sciences Biologics Dr. Reddy's Laboratories
APARNA PRABHUNE Asst GM Regulatory Affairs Wockhardt
KHOKAN DEBNATH Sr GM/(Head) – Regulatory Affairs Clinical Operations PV & QA (India & Emerging Market) Wockhardt
VISHWAS SOVANI Founder Director Pharmawisdom
Plus more joining soon
KEY THEMES DISCUSSED:
Integrated approach to biosimilar development & commercialization
Current trends and strategies to access biosimilar market
Innovative clinical approach in biosimilars & Clinical development of biosimilars
Factors that drive the selection of a biosimilar asset
Imperatives for R&D in biosimilars - Entering the next wave of growth
Addressing developmental challenges to maximize biosimilars market growth
Global Perspectives: Impact of Biosimilars around the world – What have we learned so far?
Market Access - Implications for product launch and market exclusivity
Commitment to Quality - Excellence in manufacturing biosimilars
Overcoming Barriers to the Market Access of Biosimilars
Who can influence payers on Biosimilar decision making
What type of evidence will be needed for registering Biosimilars in the future?
Outlining what investors wish inventors knew before coming to the table
RWE - What type of evidence will be needed for registering Biosimilars in the future?
Ensuring the balance between product development and patient safety
Technology: Unlocking the better ways
Regulatory - The evolving regulatory framework for biosimilar approvals
What comes next for the biosimilars market?
Be part of a major networking opportunity
WHO SHOULD ATTEND AND WHO YOU’LL MEET:
CSOs CMOs Vice Presidents Presidents Heads Directors Team Leaders and Senior Scientists from the following roles:
Biopharmaceuticals/ Biotherapeutics Follow on Biologics/Follow on Proteins Biologics/Biotechnology/ Bio generics Legal Affairs Intellectual Property Health Economics Pricing and Reimbursement Clinical Immunology Principal Scientist Chief Scientific Officer Process Control and Analytical Technologies Analytical Characterisation Regulatory Quality Affairs/ Quality Control New Product Development Process Science Portfolio Management Research & Development Business Development Business Operations Scientific Affairs Commercial Affair
Event Venue
Kohinoor Continental, Andheri - Kurla Rd, J B Nagar, Andheri East, Mumbai, Maharashtra 400059, India
INR 12980.00 to INR 18880.00
